Increased Production of Nitric Oxide Correlates with Viral Load and Activation of Mononuclear Phagocytes in HIV-infected Patients

References

• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012
   PubMed Web of Science ®Google Scholar
• Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not cytokines and lipopolysaccharide. Eur J Immunol 1994; 24: 435–439
   PubMed Web of Science ®Google Scholar
• Dennis M. Tumour necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and kill M. avium: killing mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49: 3380–3387
   Google Scholar
• Dumarey C H, Labrousse V, Rastogi N, Vargaftig B B, Bachelet M. Selective Mycobacterium avium induced production of nitric oxide by human monocyte-derived macrophages. J Leukocyte Biol 1994; 56: 36–40
   PubMed Web of Science ®Google Scholar
• Pietraforte D, Tritarelli E, Testa U, Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukocyte Biol 1994; 55: 175–182
   PubMed Web of Science ®Google Scholar
• Mautino G, Paul-Eugene N, Chanez P, Vignola A M, Kolb J P, Bousquet J, Dugas B. Heterogeneous spontaneous and interleukin-4 induced nitric oxide production by human monocytes. J Leukocyte Biol 1994; 56: 15–20
   PubMedGoogle Scholar
• Ochoa J B, Udekwu A O, Billiar T R, Curran R D, Cerra F B, Simmons R L, Peitzman A B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 21: 621–626
   Google Scholar
• Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77–81
   PubMedGoogle Scholar
• Groeneveld P HP, Ringers J, van Dissel J T. Effect of nitric oxide on renal function in septic shock. N Engl J Med 1994; 330: 1620
   PubMedGoogle Scholar
• Groeneveld P HP, Colson P, Kwappenberg K MC, Clement J. Increased production of nitric oxide (NO) in patients infected with the European variant of Hantavirus. Scand J Infect Dis 1995; 27: 453–456
   PubMed Web of Science ®Google Scholar
• Gomez-Jimenez J, Salgado A, Mourelle M, Martin M C, Segura R M, Peracaula R, Moncada S. L-Arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23: 253–258
   PubMed Web of Science ®Google Scholar
• Hibbs J B, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski R L, Ward J H, Menlove R L, McMurry M P, Kushner J P, Samlowski W E. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867–877
   PubMed Web of Science ®Google Scholar
• Nathan C F, Hibbs J B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65–70
   PubMed Web of Science ®Google Scholar
• Karupiah G, Xie Q, Mark R, Buller L, Nathan C, Duarte C, MacMicking J D. Inhibition of viral replication by interferon-induced nitric oxide synthase. Science 1993; 266: 1445–1448
   Google Scholar
• Croen K D. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex type 1 replication. J Clin Invest 1993; 91: 2446–2452
   PubMed Web of Science ®Google Scholar
• Fuchs D, Hausen A, Reibnegger G, Werner E R, Dierich P, Wachter H. Neopterin as a marker for activated cell-mediated-immunity: application in HIV infection. Immunol Today 1988; 9: 150–155
   PubMedGoogle Scholar
• Bruisten S M, Koppelman M HGM, Roos M TL, Loeliger A E, Reiss P, Boucher C AB, Huisman H G. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS 1993; 7(Suppl 2)S15–S20
   PubMedGoogle Scholar
• Evans T G, Rasmussen K, Wiebke G, Hibbs J B. Nitric oxide synthesis in patients with advanced HIV infection. Clin Exp Immunol 1994; 97: 83–86
   PubMed Web of Science ®Google Scholar
• Embretson J, Zupanic M, Ribas J L, Burke A, Racz P, Tenner-Racz K, Haase A T. Massive covert infection of helper T-lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362: 359–362
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson A W, Liew F Y, Severn A, Xu D, McSorley S J, Garside P, Padron J, Phillips R S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J lmmunol 1994; 24: 980–984
   PubMed Web of Science ®Google Scholar
• Dawson V L, Dawson T M, Uhl G R, Snyder S. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256–3259
   PubMed Web of Science ®Google Scholar
• Mollace V, Colasanti M, Rodino P, Lauro G M, Nistico G. HIV coating gp120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem Biophys Res Comm 1994; 203: 87–92
   PubMedGoogle Scholar
• Bukrinsky M I, Nottel H SLM, Schmidtmayerova H, Dubrovsky L, Flanagan C R, Mullins M E, Lipton S A, Gendelman H E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Sakai N, Kaufman S, Milstein S. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol 1993; 43: 6–10
   PubMedGoogle Scholar
• Werner-Felmayer G, Werner E R, Fuchs D, Hausen A, Reibnegger G, Wachter H. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med 1990; 172: 1599–1607
   PubMed Web of Science ®Google Scholar
• Griffin G E, Leung K, Folks T M, Kunkel S, Nabel G J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kB. Nature 1989; 339: 70–73
   PubMed Web of Science ®Google Scholar
• Akarid K, Desfors B, Pocidalo M A, Sinet M. In vitro antiviral activity of nitric oxide on the replication of murine retrovirus. In program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). American Society for Microbiology, Washington, DC 1994; 94, (abstract 1104)
   Google Scholar